ClinConnect ClinConnect Logo
Search / Trial NCT05179408

Targeted Telerehabilitation Following Curative Intent Therapy of Lung Cancer

Launched by VA OFFICE OF RESEARCH AND DEVELOPMENT · Dec 16, 2021

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Rehabilitation Exercise Training Mindfulness Training Survivorship Us Veterans Telemedicine

ClinConnect Summary

This clinical trial is looking at a new way to help Veterans who have recently finished treatment for lung cancer. After treatment, many Veterans struggle with symptoms like shortness of breath, tiredness, and feelings of anxiety about their health. The study will test a program called multi-targeted telerehabilitation, which means patients will receive rehabilitation support through video calls and online resources. The goal is to help them feel better, both physically and mentally, and improve their overall quality of life.

To be eligible for this trial, participants need to be adult Veterans who have been diagnosed with stage I-III A/B lung cancer and have completed their main treatment within the last 1 to 6 months. However, those who have serious other health issues that would make it hard to take part in exercise or follow the program will not be included. If eligible, participants can expect to receive tailored support from the comfort of their own homes, helping them to manage symptoms and improve their health after cancer treatment.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult Veterans with a history of stage I-III A/B lung cancer, and
  • Completed curative intent therapy (i.e., lung cancer resection surgery, definitive radiation, or concurrent chemoradiation) within 1-6 months
  • Exclusion Criteria:
  • * Adult Veterans with any comorbid conditions that preclude participation in exercise and telerehabilitation:
  • Orthopedic conditions (e.g., bilateral below-knee amputation), or
  • Severe cardiopulmonary disease (e.g., unstable arrhythmias including ventricular tachycardia, heart failure with systolic ejection fraction \< 25%, chronic hypoxemia needing \> 5 L/min oxygen supplementation at rest), or
  • Inability to follow directions or provide informed consent (e.g., moderate to severe dementia), or
  • Enrolled in hospice, or
  • With an estimated life expectancy of \< 6 months

About Va Office Of Research And Development

The VA Office of Research and Development (ORD) is dedicated to advancing the health and well-being of veterans through innovative research initiatives. As a pivotal sponsor of clinical trials, ORD focuses on a broad spectrum of health-related topics, including mental health, rehabilitation, and chronic disease management, ensuring that findings are directly applicable to the unique needs of the veteran population. With a commitment to scientific excellence and collaboration, ORD promotes rigorous study designs and ethical standards, facilitating the translation of research discoveries into improved clinical practices and policies that enhance veteran care.

Locations

Aurora, Colorado, United States

Aurora, Colorado, United States

Patients applied

0 patients applied

Trial Officials

Duc M. Ha, MD MAS

Principal Investigator

Rocky Mountain Regional VA Medical Center, Aurora, CO

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials